Literature DB >> 21628460

TRIM32 protein sensitizes cells to tumor necrosis factor (TNFα)-induced apoptosis via its RING domain-dependent E3 ligase activity against X-linked inhibitor of apoptosis (XIAP).

Yeung Sook Ryu1, Younglang Lee, Keun Woo Lee, Chae Young Hwang, Jin-Soo Maeng, Jeong-Hoon Kim, Yeon-Soo Seo, Kwan-Hee You, Byeongwoon Song, Ki-Sun Kwon.   

Abstract

TRIM32, which belongs to the tripartite motif (TRIM) protein family, has the RING finger, B-box, and coiled-coil domain structures common to this protein family, along with an additional NHL domain at the C terminus. TRIM32 reportedly functions as an E3 ligase for actin, a protein inhibitor of activated STAT y (PIASy), dysbindin, and c-Myc, and it has been associated with diseases such as muscular dystrophy and epithelial carcinogenesis. Here, we identify a new substrate of TRIM32 and propose a mechanism through which TRIM32 might regulate apoptosis. Our overexpression and knockdown experiments demonstrate that TRIM32 sensitizes cells to TNFα-induced apoptosis. The RING domain is necessary for this pro-apoptotic function of TRM32 as well as being responsible for its E3 ligase activity. TRIM32 colocalizes and directly interacts with X-linked inhibitor of apoptosis (XIAP), a well known cancer therapeutic target, through its coiled-coil and NHL domains. TRIM32 overexpression enhances XIAP ubiquitination and subsequent proteasome-mediated degradation, whereas TRIM32 knockdown has the opposite effect, indicating that XIAP is a substrate of TRIM32. In vitro reconstitution assay reveals that XIAP is directly ubiquitinated by TRIM32. Our novel results collectively suggest that TRIM32 sensitizes TNFα-induced apoptosis by antagonizing XIAP, an anti-apoptotic downstream effector of TNFα signaling. This function may be associated with TRIM32-mediated tumor suppressive mechanism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21628460      PMCID: PMC3138287          DOI: 10.1074/jbc.M111.241893

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus.

Authors:  Patrick Eldin; Laura Papon; Alexandra Oteiza; Emiliana Brocchi; T Glen Lawson; Nadir Mechti
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

2.  Trim11 modulates the function of neurogenic transcription factor Pax6 through ubiquitin-proteosome system.

Authors:  Tran Cong Tuoc; Anastassia Stoykova
Journal:  Genes Dev       Date:  2008-07-15       Impact factor: 11.361

3.  Deficiency in ubiquitin ligase TRIM2 causes accumulation of neurofilament light chain and neurodegeneration.

Authors:  Martin Balastik; Francesco Ferraguti; André Pires-da Silva; Tae Ho Lee; Gonzalo Alvarez-Bolado; Kun Ping Lu; Peter Gruss
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-07       Impact factor: 11.205

4.  The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD.

Authors:  Mikael Lerner; Martin Corcoran; Diana Cepeda; Michael L Nielsen; Roman Zubarev; Fredrik Pontén; Mathias Uhlén; Sophia Hober; Dan Grandér; Olle Sangfelt
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

5.  Mutations that impair interaction properties of TRIM32 associated with limb-girdle muscular dystrophy 2H.

Authors:  Valentina Saccone; Michela Palmieri; Luigia Passamano; Giulio Piluso; Germana Meroni; Luisa Politano; Vincenzo Nigro
Journal:  Hum Mutat       Date:  2008-02       Impact factor: 4.878

6.  Ro52 functionally interacts with IgG1 and regulates its quality control via the ERAD system.

Authors:  Mutsumi Takahata; Miyuki Bohgaki; Tadasuke Tsukiyama; Takeshi Kondo; Masahiro Asaka; Shigetsugu Hatakeyama
Journal:  Mol Immunol       Date:  2007-11-26       Impact factor: 4.407

7.  Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha.

Authors:  Konstantin Khetchoumian; Marius Teletin; Johan Tisserand; Manuel Mark; Benjamin Herquel; Mihaela Ignat; Jessica Zucman-Rossi; Florence Cammas; Thierry Lerouge; Christelle Thibault; Daniel Metzger; Pierre Chambon; Régine Losson
Journal:  Nat Genet       Date:  2007-11-18       Impact factor: 38.330

8.  The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors.

Authors:  Jens C Schwamborn; Eugene Berezikov; Juergen A Knoblich
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

Review 9.  The inhibitor of apoptosis proteins as therapeutic targets in cancer.

Authors:  Domagoj Vucic; Wayne J Fairbrother
Journal:  Clin Cancer Res       Date:  2007-10-15       Impact factor: 12.531

10.  Tripartite motif protein 32 facilitates cell growth and migration via degradation of Abl-interactor 2.

Authors:  Satoshi Kano; Naoto Miyajima; Satoshi Fukuda; Shigetsugu Hatakeyama
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

View more
  29 in total

1.  TRIM32 Drives Pathogenesis in Streptococcal Toxic Shock-Like Syndrome and Streptococcus suis Meningitis by Regulating Innate Immune Responses.

Authors:  Xuan OuYang; Jie Guo; Qingyu Lv; Hua Jiang; Yuling Zheng; Peng Liu; Tongyan Zhao; Decong Kong; Huaijie Hao; Yongqiang Jiang
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

2.  MicroRNA-155 Reinforces HIV Latency.

Authors:  Debbie S Ruelas; Jonathan K Chan; Eugene Oh; Amy J Heidersbach; Andrew M Hebbeler; Leonard Chavez; Eric Verdin; Michael Rape; Warner C Greene
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

3.  Interaction with the Bardet-Biedl gene product TRIM32/BBS11 modifies the half-life and localization of Glis2/NPHP7.

Authors:  Haribaskar Ramachandran; Tobias Schäfer; Yunhee Kim; Konstantin Herfurth; Sylvia Hoff; Soeren S Lienkamp; Albrecht Kramer-Zucker; Gerd Walz
Journal:  J Biol Chem       Date:  2014-02-05       Impact factor: 5.157

4.  Satellite cell senescence underlies myopathy in a mouse model of limb-girdle muscular dystrophy 2H.

Authors:  Elena Kudryashova; Irina Kramerova; Melissa J Spencer
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

Review 5.  The cell biology of TRIM5α.

Authors:  Zana Lukic; Edward M Campbell
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

6.  TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels.

Authors:  Ankush Borlepawar; Ashraf Yusuf Rangrez; Alexander Bernt; Lynn Christen; Samuel Sossalla; Derk Frank; Norbert Frey
Journal:  J Biol Chem       Date:  2017-05-02       Impact factor: 5.157

7.  TRIM proteins and cancer.

Authors:  Shigetsugu Hatakeyama
Journal:  Nat Rev Cancer       Date:  2011-10-07       Impact factor: 60.716

8.  Expression of the Parkinson's Disease-Associated Gene Alpha-Synuclein is Regulated by the Neuronal Cell Fate Determinant TRIM32.

Authors:  Maria Angeliki S Pavlou; Nicoló Colombo; Sandra Fuertes-Alvarez; Sarah Nicklas; Laura Gonzalez Cano; Maria C Marín; Jorge Goncalves; Jens C Schwamborn
Journal:  Mol Neurobiol       Date:  2016-06-23       Impact factor: 5.590

9.  Drosophila TRIM32 cooperates with glycolytic enzymes to promote cell growth.

Authors:  Simranjot Bawa; David S Brooks; Kathryn E Neville; Marla Tipping; Md Abdul Sagar; Joseph A Kollhoff; Geetanjali Chawla; Brian V Geisbrecht; Jason M Tennessen; Kevin W Eliceiri; Erika R Geisbrecht
Journal:  Elife       Date:  2020-03-30       Impact factor: 8.140

10.  Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.

Authors:  Qi Li; Cheng Hiang Lee; Lauren A Peters; Lucas A Mastropaolo; Cornelia Thoeni; Abdul Elkadri; Tobias Schwerd; Jun Zhu; Bin Zhang; Yongzhong Zhao; Ke Hao; Antonio Dinarzo; Gabriel Hoffman; Brian A Kidd; Ryan Murchie; Ziad Al Adham; Conghui Guo; Daniel Kotlarz; Ernest Cutz; Thomas D Walters; Dror S Shouval; Mark Curran; Radu Dobrin; Carrie Brodmerkel; Scott B Snapper; Christoph Klein; John H Brumell; Mingjing Hu; Ralph Nanan; Brigitte Snanter-Nanan; Melanie Wong; Francoise Le Deist; Elie Haddad; Chaim M Roifman; Colette Deslandres; Anne M Griffiths; Kevin J Gaskin; Holm H Uhlig; Eric E Schadt; Aleixo M Muise
Journal:  Gastroenterology       Date:  2016-02-04       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.